Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Clinical trials often exclude key patient populations, including children and people living with HIV or hepatitis B or C.
Nearly 3,800 patients at the New Jersey surgery center may have been exposed, though the risk of infection is low.
New technology and innovative approaches may speed diagnosis of this liver virus.
Liver cancer rates and deaths have doubled in the United States, Canada, Australia and United Kingdom.
A brief overview of the differences between hepatitis A, B and C.
Hepatitis B patients who used aspirin therapy had a 37 percent lower rate of hepatocellular carcinoma.
Men and people over age 50 still may still develop liver cancer after clearing the virus from the blood.
Low but detectable HBV DNA during antiviral therapy is associated with detrimental long-term outcomes.
The annual awareness day is held every year on July 28. This year’s theme aims to put a human face to the epidemic.
Treatment with Viread and Baraclude led to a decline in liver cancer in Europe but not in South Korea.
The majority of cases are preventable, for example through early detection and treatment, hepatitis B vaccination and hepatitis C treatment.
Can we eliminate hepatitis C the way we did to small pox? Experts think we can, and many believe we can also eradicate hepatitis B.
The national health organization’s 2017 advisory report now includes advice on 13 vaccinations for U.S. adults.
Could one of these chronic health conditions be raising the risk of the other?
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.